from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0140/-

LFCtreatmentdescriptionclass of inhibitor

0.119

Amikacinug/mL Amikacintranslation

0.579

Cap5-10ug/mL Capreomycintranslation

0.563

Rox10-50 ug/mL Roxithromycintranslation

0.070

SM2-5 ug/mL Streptomycintranslation

0.513

Tet5-10 ug/mL Tetracyclinetranslation

-0.781

Rif0.2-5ug/mL Rifampicintranscription

-0.313

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.331

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.209

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.672

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.481

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.499

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.708

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.815

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.189

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.791

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.504

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.982

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.332

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

2.457

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.927

KCN5-20 ug/mL Potassium cyaniderespiration

0.150

NaN30.2-2 mM Sodium aziderespiration

1.460

Nigericin50 uM Nigericinrespiration

1.877

TRC10-150 ug/mL Triclosanrespiration

-0.131

TRZ10-25 ug/mL Thioridazinerespiration

-0.804

Valinomycin0.5-10 uM Valinomycinrespiration

-0.501

ZnSO42 mM ZnSO4respiration

2.678

menadione6-10 ug/mL Menadionerespiration

-1.039

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.526

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.369

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.430

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.059

NRP_1Non-replicating persistence stage 1dosRassociated

-0.650

Amp0.2mg/mL AmpicillincellWall

-0.544

Cephalexin20-100 ug/mL CephalexincellWall

-0.526

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.477

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.917

EMB10-20 ug/mL EthambutolcellWall

-0.828

Eta12-40 ug/mL EthionamidecellWall

-0.667

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.598

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.828

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.925

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.196

BZA0.12 mg/mL BenzamidearomaticAmides

1.145

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.099

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.171

H2O24 mM hydrogen peroxideDNAdamaging

-0.634

Levo10 ug/mL LevofloxacinDNAdamaging

-0.213

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.593

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.008

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.328

UVUV-irradiationDNAdamaging

2.512

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.677

Antimycin12.5-50 ug/mL Antimycin A?

-0.358

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.455

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.218

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.030

PA8240.2-2 ug/mL PA-824?

-0.900

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.437

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.760

Verapamil50 uM Verapamil?

0.410

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.522

methoxatin10-20 ug/mL Methoxatin?